The role of hypervirulent Staphylococcus aureus infections in the development of deep vein thrombosis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Thrombosis Research

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.thromres.2012.06.013PMID 22771217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and microbiological characteristics of communityacquired methicillin-resistant Staphylococcus aureus pneumonia

  2012cited by this paper
• Inflammation and haemostasis

  2012cited by this paper
• Hypercoagulability and Hypofibrinolysis and Risk of Deep Vein Thrombosis and Splanchnic Vein Thrombosis: Similarities and Differences

  2011cited by this paper
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

  2011cited by this paper
• A young adult with a fulminant Staphylococcus aureus infection and multiple thrombi

  2011cited by this paper
• Development of a vaccine against Staphylococcus aureus

  2011cited by this paper
• Systemic versus localized coagulation activation contributing to organ failure in critically ill patients

  2011cited by this paper
• Deep venous thrombosis associated with acute hematogenous osteomyelitis in children.

  2010cited by this paper
• Platelet–bacterial interactions

  2010cited by this paper
• The coagulant response in sepsis and inflammation

  2010cited by this paper
• Activation and damage of endothelial cells upon hypoxia/reoxygenation. Effect of extracellular pH

  2009cited by this paper
• Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host.

  2009cited by this paper
• Comparison of community-acquired pneumonia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus producing the Panton-Valentine leukocidin.

  2009cited by this paper
• Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus

  2009cited by this paper
• Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)*

  2009cited by this paper
• Regulatory mechanisms of C4b‐binding protein (C4BP)α and β expression in rat hepatocytes by lipopolysaccharide and interleukin‐6

  2008cited by this paper
• Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases

  2008cited by this paper
• Early intravenous unfractionated heparin and mortality in septic shock*

  2008cited by this paper
• Fibrinogen Binding Sites P336 and Y338 of Clumping Factor A Are Crucial for Staphylococcus aureus Virulence

  2008cited by this paper
• Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.

  2008cited by this paper
• The coagulant response in sepsis.

  2008cited by this paper
• Deep venous thrombosis associated with osteomyelitis in children.

  2007cited by this paper
• Severe Microvascular Injury Induced by Lysosomal Releasates of Human Polymorphonuclear Leukocytes Increase in Vasopermeability, Hemorrhage, and Microthrombosis Due to Degradation of Subendothelial and Perivascular Matrices

  2007cited by this paper
• Vascular bed‐specific thrombosis

  2007cited by this paper
• Community‐acquired methicillin‐resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: Literature review and recommendations for management

  2007cited by this paper
• Molecular Basis for Staphylococcus aureus–Mediated Platelet Aggregate Formation Under Arterial Shear In Vitro

  2007cited by this paper
• Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells

  2007cited by this paper
• Evolving functions of endothelial cells in inflammation

  2007cited by this paper
• Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock*

  2007cited by this paper
• Etiology and consequences of thrombosis in abdominal vessels.

  2006cited by this paper
• Venous Thrombosis Associated With Staphylococcal Osteomyelitis in Children

  2006cited by this paper
• Fibronectin‐binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcγRIIa receptor

  2006cited by this paper
• Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.

  2006cited by this paper
• Venous thrombosis and thromboembolism in children with osteomyelitis.

  2006cited by this paper
• Powerful Inflammatory Properties of Large Vein Endothelium In Vivo

  2005cited by this paper
• Expression of staphylococcal clumping factor A impedes macrophage phagocytosis.

  2004cited by this paper
• Clumping Factor B, a Fibrinogen-binding MSCRAMM (Microbial Surface Components Recognizing Adhesive Matrix Molecules) Adhesin of Staphylococcus aureus, Also Binds to the Tail Region of Type I Cytokeratin 10*

  2004cited by this paper
• MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infection.

  2004cited by this paper
• Bidirectional Relation Between Inflammation and Coagulation

  2004cited by this paper
• Fluid Shear Regulates the Kinetics and Receptor Specificity of Staphylococcus aureus Binding to Activated Platelets1

  2004cited by this paper
• Early coagulopathy predicts mortality in trauma.

  2003cited by this paper
• Mechanism of venous valve closure and role of the valve in circulation: a new concept.

  2003cited by this paper
• Sepsis and Disseminated Intravascular Coagulation

  2003cited by this paper
• D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients.

  2002cited by this paper
• Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization

  2002cited by this paper
• Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein SdrE and protein A

  2002cited by this paper
• Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions.

  2002cited by this paper
• Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis

  2001cited by this paper
• Adherence Properties of Staphylococcus aureus under Static and Flow Conditions: Roles of agrand sar Loci, Platelets, and Plasma Ligands

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Dysfunction of endothelial protein C activation in severe meningococcal sepsis.

  2001cited by this paper
• Practical utility of the D-dimer assay for excluding thromboembolism in severely injured trauma patients.

  2001cited by this paper
• Staphylococcus aureus Protein A Recognizes Platelet gC1qR/p33: a Novel Mechanism for Staphylococcal Interactions with Platelets

  2000cited by this paper
• The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis.

  2000cited by this paper
• HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY only. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus

  2000cited by this paper
• Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines.

  1999cited by this paper
• Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis.

  1999cited by this paper
• Treating patients with severe sepsis.

  1999cited by this paper
• Disseminated Intravascular Coagulation

  1999cited by this paper
• Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo.

  1998cited by this paper
• Surface protein adhesins of Staphylococcus aureus.

  1998cited by this paper
• Antithrombin III in patients with severe sepsis

  1998cited by this paper
• Derangements of Coagulation and Fibrinolysis in Critically III Patients with Sepsis and Septic Shock

  1998cited by this paper
• Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis.

  1998cited by this paper
• EFFECT OF ANTITHROMBIN III SUPPLEMENTATION ON INFLAMMATORY RESPONSE IN PATIENTS WITH SEVERE SEPSIS

  1998cited by this paper
• Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.

  1998cited by this paper
• Significant Correlations between Tissue Factor and Thrombin Markers in Trauma and Septic Patients with Disseminated Intravascular Coagulation

  1998cited by this paper
• Tissue Factor Pathway Inhibitor: Potential Therapeutic Applications

  1997cited by this paper
• The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.

  1996cited by this paper
• The incidence and cause of coagulopathies in an intensive care population

  1996cited by this paper
• Determinants of splanchnic blood flow.

  1996cited by this paper
• Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes.

  1995cited by this paper
• Hematology: Basic Principles and Practice

  1995cited by this paper
• Sites of Tissue Factor Pathway Inhibitor (TFPI) and Tissue Factor Expression under Physiologic and Pathologic Conditions

  1995cited by this paper
• Oxygen transport-dependent splanchnic metabolism in the sepsis syndrome.

  1994cited by this paper
• MSCRAMM-mediated adherence of microorganisms to host tissues.

  1994cited by this paper
• Identification of a novel 33-kDa C1q-binding site on human blood platelets.

  1994cited by this paper
• Distribution of Tissue Factor Pathway Inhibitor in Normal and Malignant Human Tissues

  1993cited by this paper
• Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.

  1993cited by this paper
• Regional blood flow and oxygen transport in septic shock

  1993cited by this paper
• Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.

  1992cited by this paper
• The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity.

  1991cited by this paper
• Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

  1990cited by this paper
• Plasma thrombomodulin in health and diseases.

  1990cited by this paper
• The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.

  1990cited by this paper
• The role of endothelial cells in inflammation.

  1990cited by this paper
• Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis.

  1990cited by this paper
• Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

  1989cited by this paper
• Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.

  1988cited by this paper
• Neutrophil granule constituents and their release in health and disease.

  1988cited by this paper
• Heparin promotes the inactivation of antithrombin by neutrophil elastase.

  1987cited by this paper
• Splanchnic and total body oxygen consumption differences in septic and injured patients.

  1987cited by this paper
• Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain.

  1986cited by this paper
• Modulation of endothelial cell hemostatic properties by tumor necrosis factor

  1986cited by this paper
• Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain

  1986cited by this paper
• Purification of human brain tissue factor.

  1985cited by this paper
• Severe microvascular injury induced by lysosomal releasates of human polymorphonuclear leukocytes. Increase in vasopermeability, hemorrhage, and microthrombosis due to degradation of subendothelial and perivascular matrices.

  1985cited by this paper
• Profound but reversible myocardial depression in patients with septic shock.

  1984cited by this paper
• The PO2 in venous valve pockets: Its possible bearing on thrombogenesis

  1981cited by this paper
• Purification and characterization of bovine tissue factor.

  1981cited by this paper

• Bacterial interactions with platelets: defining key themes

  2025cites this paper
• Respuestas al caso clínico ''Presentación concomitante de infecciones musculoesqueléticas, un reto diagnóstico en Pediatría''¹

  2025cites this paper
• Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis

  2025cites this paper
• Optimising detection of thrombosis in paediatric Staphylococcus aureus bacteraemia: A prospective interventional sub-study protocol.

  2024cites this paper
• Contribution of staphylococcal virulence factors in the pathogenesis of thrombosis.

  2024cites this paper
• Infection, Inflammation, Venous Thromboembolism: A Co-existence

  2023cites this paper
• Ampelopsin attenuates Staphylococcus aureus Alpha-Toxin-Induced Lung Injury.

  2023cites this paper
• The Underlying Molecular Basis and Mechanisms of Venous Thrombosis in Patients with Osteomyelitis: A Data-Driven Analysis

  2022cites this paper
• Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the Literature

  2022cites this paper
• Intracranial thrombosis associated with MSSA bacteraemia in the setting of influenza A

  2021cites this paper
• Association of clinical and laboratory variables with in-hospital incidence of deep vein thrombosis in patients after acute ischemic stroke

  2021influential citation
• Host fibrinogen drives antimicrobial function in Staphylococcus aureus peritonitis through bacterial-mediated prothrombin activation

  2020cites this paper
• Association of Clinical and Laboratory Variables with In-Hospital Incidence of Deep Vein Thrombosis in Patients with Acute Stroke: A Retrospective Study

  2020cites this paper
• ILEOFEMORAL THROMBOSIS AS A COMPLICATION OF ACUTE HEMATOGENOUS OSTEOMYELITIS OF THE FEMORAL BONE IN A 3-YEAR-OLD CHILD

  2019cites this paper
• Risk Factors for Myocardial Infarction and Stroke Among Sepsis Survivors: A Competing Risks Analysis

  2019cites this paper
• Panton-Valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion products

  2018cites this paper
• Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia

  2018cites this paper
• Panton-Valentine Leukocidin Positive Methicillin-Susceptible Staphylococcus aureus: A Case Report of Two Pediatric Patients with Thrombotic Complications

  2018cites this paper
• [Ecthyma gangrenosum associated with infection involving a methicillin-sensitive, Panton-Valentine-negative strain of Staphylococcus aureus].

  2015cites this paper
• Thromboresistant/anti-biofilm catheters via electrochemically modulated nitric oxide release.

  2015cites this paper
• [Septic deep venous thrombosis secondary to acute osteomyelitis, septic arthritis and piomyositis due to Staphylococcus aureus in 3 Costa Rican children].

  2015cites this paper
• Increased Expressions of Integrin Subunit β1, β2 and β3 in Patients with Acute Infection

  2015cites this paper
• Risk for Myocardial Infarction and Stroke After Community-Acquired Bacteremia: A 20-Year Population-Based Cohort Study

  2014cites this paper
• Effect of Ascorbate on Coagulation and Fibrinolytic Factors in the Septic Microvasculature

  2014cites this paper
• Prognosis of adults admitted to medical departments with community-acquired bacteremia

  2014cites this paper
• Venous Thromboembolism after Community-Acquired Bacteraemia: A 20-year Danish Cohort Study

  2014cites this paper
• Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration

  2013cites this paper
• Interference of Staphylococcus aureus virulence factors in the blood coagulation system

  2013cites this paper
• Plaquettes sanguines et entretien de l’inflammation post-infectieuse

  2013cites this paper